XML 48 R37.htm IDEA: XBRL DOCUMENT v3.7.0.1
REVERSE MERGER (Pro-forma Disclosures) (Details) - Transgenomics - USD ($)
$ / shares in Units, $ in Thousands
6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Business Acquisition [Line Items]    
Net sales $ 1,472 $ 1,783
Net loss available to common stockholders $ (13,864) $ (13,266)
Loss per common share (usd per share) $ (2.16) $ (2.07)